Researchers have discovered a method of restoring sweat gland function in burn victims.

The Indigenous Skin Spectrum Summit will be held on Friday, Oct. 4, followed by the Skin Spectrum Summit on Saturday, Oct 5.

Patients with HS are at an increased risk of anxiety disorders.

Older adults taking antihypertensive drugs are at an increased risk of eczematous dermatitis.

The visibility of a skin disorder is directly linked to stigma including bullying.

Hidradenitis suppurativa patients are at higher risk for respiratory diseases.

There are significant delays in diagnosis and low implementation rates for treatment for HS.

Lutikizumab 300 mg was shown to be more effective than placebo in HS patients.